Institutional investors purchased a net $74.1 thousand shares of IDIX during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 72.83% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE BAUPOST GROUP LLC Bought 5.3 Million shares of Idenix Pharmaceuticals In...
CAMBER CAPITAL MANAGEMENT LLC Bought 1.1 Million shares of Idenix Pharmaceuticals In...